Latest Revenue Performance News

Page 3 of 4
Globe International Limited reported a decline in revenue and profit for FY25, reflecting a strategic shift away from non-core brands. Despite this, the company maintains strong profitability in Australia and a solid cash position, while declaring a fully franked dividend of 20 cents per share.
Victor Sage
Victor Sage
21 Aug 2025
Simonds Group delivered stable FY25 revenue and modest EBITDA growth despite one-off acquisition expenses, positioning itself for growth through strategic product and channel expansion in FY26.
Victor Sage
Victor Sage
18 Aug 2025
IODM Limited has triggered a significant increase in its guaranteed minimum monthly revenue from its UK Education segment, reflecting a remarkable 242% growth in July 2025 compared to last year. This milestone boosts the annualised minimum payment to AUD 2.39 million, underscoring the strength of its digital accounts receivable platform.
Sophie Babbage
Sophie Babbage
11 Aug 2025
Nutritional Growth Solutions revises its Q2 FY25 financials, confirming stable revenue and detailing expanded distribution into CVS and Walmart. The company is actively raising capital to support growth and improve liquidity.
Victor Sage
Victor Sage
5 Aug 2025
Hydrix Limited reports steady June quarter revenues with a 10% rise from the prior quarter, supported by new contract wins and a robust $40 million project pipeline.
Ada Torres
Ada Torres
31 July 2025
Rhythm Biosciences has successfully validated its ColoSTAT® colorectal cancer test, secured its first strategic partnership for Genetype, and secured $1 million in non-dilutive funding, setting the stage for a transformative FY26.
Ada Torres
Ada Torres
31 July 2025
Bioxyne Limited reports a record-breaking Q4 FY25 with revenue soaring 204% year-on-year and a strategic entry into the German market through a €3.2 million manufacturing agreement.
Victor Sage
Victor Sage
24 July 2025
Control Bionics is on track for its strongest financial year yet, driven by robust US and Australian sales and promising global trials of its NeuroStrip® device.
Ada Torres
Ada Torres
13 June 2025
Little Green Pharma invites shareholders to a detailed FY2025 financial results webinar, promising insights into profitability, revenue growth, and recent financing achievements.
Ada Torres
Ada Torres
10 June 2025
Chorus Limited’s 2024 fibre regulatory report reveals a stable $5.9 billion asset base and revenue close to the maximum allowed, with a $153.5 million wash-up balance carried forward.
Sophie Babbage
Sophie Babbage
30 May 2025
The Australian Wealth Advisors Group has deepened its Equity Partnership Scheme with strategic stakes in Oneledger and B2B Invest, setting up royalty revenue streams that align with its expansion in financial services.
Claire Turing
Claire Turing
22 May 2025
oOh!media Limited reports robust revenue growth momentum continuing into 2025, driven by strong contract wins and disciplined cost management. The company expects sustained market share gains in the expanding Out of Home advertising sector.
Victor Sage
Victor Sage
15 May 2025

Browse the archive

Full archive